Publikationen - Institut für Radiopharmazeutische Krebsforschung - Jahr 2020
14 Publikationen2020
The pyrazolo[3,4-d]pyrimidine-based kinase inhibitor NVP-BHG712: Effects of regioisomers on tumor growth, perfusion, and hypoxia in EphB4-positive A375 melanoma xenografts
Neuber, C.; Tröster, A.; Löser, R.; Belter, B.; Schwalbe, H.; et al. (6 authors)
-
Molecules 25(2020), 5115
DOI: 10.3390/molecules25215115
Three-dimensional cell culture systems in radiopharmaceutical cancer research
Doctor, A.; Seifert, V.; Ullrich, M.; Hauser, S.; Pietzsch, J.
-
Cancers 12(2020), 2765
DOI: 10.3390/cancers12102765
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas
Bechmann, N.; Moskopp, M. L.; Ullrich, M.; Calsina, B.; Wallace, P. W.; et al. (23 authors)
-
Endocrine-Related Cancer 27(2020)11, 625-640
DOI: 10.1530/ERC-20-0205
The influence of different artificial extracellular matrix implant coatings on the regeneration of a critical size femur defect in rats
Förster, Y.; Schulze, S.; Penk, A.; Neuber, C.; Möller, S.; et al. (11 authors)
-
Materials Science and Engineering C 116(2020), 111157
DOI: 10.1016/j.msec.2020.111157
Recent insights in barium-131 as a diagnostic match for radium-223: cyclotron production, separation, labeling and imaging
Reissig, F.; Bauer, D.; Ullrich, M.; Kreller, M.; Pietzsch, J.; et al. (9 authors)
-
Pharmaceuticals 13(2020)10, 272
DOI: 10.3390/ph13100272
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
Wallace, P. W.; Conrad, C.; Brückmann, S.; Pang, Y.; Caleiras, E.; et al. (26 authors)
-
The Journal of Pathology 251(2020), 378-387
DOI: 10.1002/path.5472
ISSN: 1096-9896
Deuteration versus ethylation – strategies to improve the metabolic fate of a 18F-labeled celecoxib derivative
Laube, M.; Gassner, C.; Neuber, C.; Wodtke, R.; Ullrich, M.; et al. (12 authors)
-
RSC Advances 10(2020), 38601-38611
DOI: 10.1039/D0RA04494F
A radiopharmacologist's and radiochemist's view on targeting the Eph/ephrin receptor tyrosine kinase system
Neuber, C.; Belter, B.; Mamat, C.; Pietzsch, J.
-
ACS Omega 5(2020)27, 16318-16331
DOI: 10.1021/acsomega.0c01058
Adjuvant drug-assisted bone healing: advances and challenges in drug delivery approaches
Rothe, R.; Hauser, S.; Neuber, C.; Laube, M.; Schulze, S.; et al. (7 authors)
-
Pharmaceutics 12(2020), 428
DOI: 10.3390/pharmaceutics12050428
ISSN: 1999-4923
Synthesis, radiolabeling and first biological characterization of 18F-labeled xanthine derivatives for PET imaging of Eph receptors
Pretze, M.; Neuber, C.; Kinski, E.; Belter, B.; Köckerling, M.; et al. (9 authors)
-
Organic & Biomolecular Chemistry 18(2020)16, 3104-3116
DOI: 10.1039/D0OB00391C
Regulation of bone regeneration
-
Clinical Hemorheology and Microcirculation 73(2020)3, 379-380
DOI: 10.3233/CH-199101
ISSN: 1386-0291
Carboranyl Derivatives of Rofecoxib with Cytostatic Activity Against Human Melanoma and Colon Cancer Cells
Buzharevski, A.; Paskas, S.; Sárosi, M.-B.; Laube, M.; Lönnecke, P.; et al. (11 authors)
-
Scientific Reports 10(2020), 4827
DOI: 10.1038/s41598-020-59059-3
The sigma-1 receptor: potential role in the modulation of cellular radiation sensitivity
Belter, B.; Deuther-Conrad, W.; Hofheinz, F.; Bachmann, M.; Brust, P.; et al. (6 authors)
-
Journal of Cellular Biotechnology 6(2020), 13-21
DOI: 10.3233/JCB-209007
Active Targeting of Dendritic Polyglycerols for Diagnostic Cancer Imaging
Kritee, P.; Neuber, C.; Zarschler, K.; Wodtke, J.; Meister, S.; et al. (8 authors)
-
Small 16(2020)7, 1905013
Online First (2019) DOI: 10.1002/smll.201905013
Jahre: 2024 2023 2022 2021 2020 2019 2018 2017 2016
